Moneycontrol PRO
you are here: HomeNewsOpinion

Corporate Corridor | Pfizer’s Upjohn and Mylan combining forces holds lessons for Indian pharma majors

The merger of Pfizer’s Upjohn division and Mylan may not only attempt to solve their problems in the US market but also make inroads into emerging markets, particularly China

July 29, 2019 / 02:42 PM IST
Corporate Corridor | Pfizer’s Upjohn and Mylan combining forces holds lessons for Indian pharma majors

In the US pharmaceutical market, the distribution channels have been consolidating for some years now, resulting in a few large companies squeezing drug companies for the best deals and discounts. Price erosion due to this consolidation or growing competition has become a constant refrain in earnings discussions of generic companies. One way to tackle that is for the sellers to consolidate but that’s been slow to take off. Pfizer’s decision to combine with Mylan for generics could trigger a...

  • PRO Panorama

    Moneycontrol Pro Panorama | New COVID variant gives market a heart attack

    Nov 26, 2021 / 04:18 PM IST

    In today’s edition of Moneycontrol Pro Panorama: Market swoons, the mutating virus, LIC IPO, RIL’s clean energy bet, the Weekly Tactical, the Immunity Tracker, the Ola EV hype and more

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers